The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition. Academic Article uri icon

Overview

abstract

  • Aggressive B-cell malignancies, such as mantle cell lymphoma (MCL), are microenvironment-dependent tumors and a better understanding of the dialogs occurring in lymphoma-protective ecosystems will provide new perspectives to increase treatment efficiency. To identify novel molecular regulations, we performed a transcriptomic analysis based on the comparison of circulating MCL cells (n=77) versus MCL lymph nodes (n=107) together with RNA sequencing of malignant (n=8) versus normal B-cell (n=6) samples. This integrated analysis led to the discovery of microenvironment-dependent and tumor-specific secretion of interleukin-32 beta (IL32β), whose expression was confirmed in situ within MCL lymph nodes by multiplex immunohistochemistry. Using ex vivo models of primary MCL cells (n=23), we demonstrated that, through the secretion of IL32β, the tumor was able to polarize monocytes into specific MCL-associated macrophages, which in turn favor tumor survival. We highlighted that while IL32β-stimulated macrophages secreted several protumoral factors, they supported tumor survival through a soluble dialog, mostly driven by BAFF. Finally, we demonstrated the efficacy of selective NIK/alternative-NFkB inhibition to counteract microenvironment-dependent induction of IL32β and BAFF-dependent survival of MCL cells. These data uncovered the IL32β/BAFF axis as a previously undescribed pathway involved in lymphoma-associated macrophage polarization and tumor survival, which could be counteracted through selective NIK inhibition.

authors

  • Decombis, Salomé
  • Papin, Antonin
  • Bellanger, Céline
  • Sortais, Clara
  • Dousset, Christelle
  • Le Bris, Yannick
  • Riveron, Thiphanie
  • Blandin, Stéphanie
  • Hulin, Philippe
  • Tessoulin, Benoit
  • Rouel, Mathieu
  • Le Gouill, Steven
  • Moreau-Aubry, Agnès
  • Pellat-Deceunynck, Catherine
  • Chiron, David

publication date

  • December 1, 2022

Research

keywords

  • B-Cell Activating Factor
  • Interleukins
  • Lymphoma, Mantle-Cell
  • Protein Serine-Threonine Kinases

Identity

PubMed Central ID

  • PMC9713562

Scopus Document Identifier

  • 85132193658

Digital Object Identifier (DOI)

  • 10.21203/rs.3.pex-1336/v1

PubMed ID

  • 35263985

Additional Document Info

volume

  • 107

issue

  • 12